BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

843 related articles for article (PubMed ID: 15493010)

  • 1. JAK and STAT proteins are expressed and activated by IFN-gamma in rat pancreatic acinar cells.
    Gallmeier E; Schäfer C; Moubarak P; Tietz A; Plössl I; Huss R; Göke B; Wagner AC
    J Cell Physiol; 2005 Apr; 203(1):209-16. PubMed ID: 15493010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells.
    Huang JS; Guh JY; Hung WC; Yang ML; Lai YH; Chen HC; Chuang LY
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):231-8. PubMed ID: 10432321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AG490 prevents cell death after exposure of rat astrocytes to hydrogen peroxide or proinflammatory cytokines: involvement of the Jak2/STAT pathway.
    Gorina R; Petegnief V; Chamorro A; Planas AM
    J Neurochem; 2005 Feb; 92(3):505-18. PubMed ID: 15659221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential requirements for JAK2 and TYK2 in T cell proliferation and IFN-gamma production induced by IL-12 alone or together with IL-18.
    Sugimoto N; Nakahira M; Ahn HJ; Micallef M; Hamaoka T; Kurimoto M; Fujiwara H
    Eur J Immunol; 2003 Jan; 33(1):243-51. PubMed ID: 12594853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I and type II interferons delay human neutrophil apoptosis via activation of STAT3 and up-regulation of cellular inhibitor of apoptosis 2.
    Sakamoto E; Hato F; Kato T; Sakamoto C; Akahori M; Hino M; Kitagawa S
    J Leukoc Biol; 2005 Jul; 78(1):301-9. PubMed ID: 15845643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPK and Stat1 in IFN-gamma, but not IFN-alpha, signaling.
    Takaoka A; Tanaka N; Mitani Y; Miyazaki T; Fujii H; Sato M; Kovarik P; Decker T; Schlessinger J; Taniguchi T
    EMBO J; 1999 May; 18(9):2480-8. PubMed ID: 10228162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli.
    Banes AK; Shaw S; Jenkins J; Redd H; Amiri F; Pollock DM; Marrero MB
    Am J Physiol Renal Physiol; 2004 Apr; 286(4):F653-9. PubMed ID: 14678947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide YY attenuates STAT1 and STAT3 activation induced by TNF-alpha in acinar cell line AR42J.
    Robinson K; Vona-Davis L; Riggs D; Jackson B; McFadden D
    J Am Coll Surg; 2006 May; 202(5):788-96. PubMed ID: 16648019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
    Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
    Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement for distinct Janus kinases and STAT proteins in T cell proliferation versus IFN-gamma production following IL-12 stimulation.
    Ahn HJ; Tomura M; Yu WG; Iwasaki M; Park WR; Hamaoka T; Fujiwara H
    J Immunol; 1998 Dec; 161(11):5893-900. PubMed ID: 9834069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of differentiation by IL-6-type cytokines is impaired in myeloid leukaemia cells unable to activate Stat5a.
    Piekorz RP; Hocke GM
    Cytokine; 1997 Sep; 9(9):639-49. PubMed ID: 9325012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes.
    McWhinney CD; Dostal D; Baker K
    J Mol Cell Cardiol; 1998 Apr; 30(4):751-61. PubMed ID: 9602424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha.
    Li S; Labrecque S; Gauzzi MC; Cuddihy AR; Wong AH; Pellegrini S; Matlashewski GJ; Koromilas AE
    Oncogene; 1999 Oct; 18(42):5727-37. PubMed ID: 10523853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
    Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
    J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Janus kinase-signal transducer and activator of transcription mediates phosphatidic acid-induced interleukin (IL)-1beta and IL-6 production.
    Lee C; Lim HK; Sakong J; Lee YS; Kim JR; Baek SH
    Mol Pharmacol; 2006 Mar; 69(3):1041-7. PubMed ID: 16354768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cytokine-induced JAK-STAT signalling pathways by an endonuclease inhibitor aurintricarboxylic acid.
    Chen CW; Chao Y; Chang YH; Hsu MJ; Lin WW
    Br J Pharmacol; 2002 Dec; 137(7):1011-20. PubMed ID: 12429573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrphostin B42 inhibits IL-12-induced tyrosine phosphorylation and activation of Janus kinase-2 and prevents experimental allergic encephalomyelitis.
    Bright JJ; Du C; Sriram S
    J Immunol; 1999 May; 162(10):6255-62. PubMed ID: 10229872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esophageal keratinocytes.
    Andl CD; Mizushima T; Oyama K; Bowser M; Nakagawa H; Rustgi AK
    Am J Physiol Gastrointest Liver Physiol; 2004 Dec; 287(6):G1227-37. PubMed ID: 15284024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive activation of STAT transcription factors in acute myelogenous leukemia.
    Spiekermann K; Biethahn S; Wilde S; Hiddemann W; Alves F
    Eur J Haematol; 2001 Aug; 67(2):63-71. PubMed ID: 11722592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
    Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
    Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.